tiprankstipranks
Niagen Bioscience (NAGE)
NASDAQ:NAGE
US Market

Niagen Bioscience (NAGE) Income Statement

651 Followers

Niagen Bioscience Income Statement

Last quarter (Q4 2025), Niagen Bioscience's total revenue was $33.84M, an increase of 16.19% from the same quarter last year. In Q4, Niagen Bioscience's net income was $4.13M. See Niagen Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 129.42M$ 99.60M$ 83.57M$ 72.05M$ 67.45M
Gross Profit
$ 83.19M$ 61.59M$ 50.78M$ 42.80M$ 41.49M
Operating Expenses
$ 68.89M$ 53.86M$ 56.38M$ 61.42M$ 68.56M
Depreciation and Amortization
$ 1.45M$ 1.48M$ 1.71M$ 1.88M$ 1.63M
EBITDA
$ 15.75M$ 9.21M$ -3.89M$ -16.74M$ -25.45M
Operating Income
$ 14.30M$ 7.73M$ -5.60M$ -18.63M$ -27.07M
Other Income/Expenses
$ 3.90M$ 1.13M$ 661.00K$ 2.09M$ -55.00K
Pretax Income
$ 18.19M$ 8.86M$ -4.94M$ -16.54M$ -27.13M
Net Income
$ 17.38M$ 8.55M$ -4.94M$ -16.54M$ -27.13M
Per Share Metrics
Basic EPS
$ 0.22$ 0.10$ -0.07$ -0.24$ -0.40
Diluted EPS
$ 0.20$ 0.11$ -0.07$ -0.24$ -0.40
Weighted Average Shares Outstanding
79.18M 85.42M 70.54M 68.92M 67.19M
Weighted Average Shares Outstanding (Diluted)
85.44M 79.72M 74.98M 69.73M 67.19M
Currency in USD

Niagen Bioscience Earnings and Revenue History